Alexis Dormandy, Oxford Science Enterprises CEO

Ox­ford Sci­ence En­ter­pris­es col­lects $300M to of­fer spin­outs 's­cale-up cap­i­tal'

For the past sev­en years, biotech spin­outs from the Uni­ver­si­ty of Ox­ford have of­ten tapped in­to a re­li­able source of in­vest­ments from Ox­ford Sci­ence En­ter­pris­es, the com­pa­ny tasked with found­ing, fund­ing and build­ing star­tups based on “ex­cep­tion­al sci­ence” flow­ing out of Ox­ford.

And the pool has got­ten $300 mil­lion (£250 mil­lion) deep­er as Ox­ford Sci­ence En­ter­pris­es bags a new raise that puts its tal­ly over $1 bil­lion (£850 mil­lion).

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.